Association of Amount of Weight Lost After Bariatric Surgery With Intracranial Pressure in Women With Idiopathic Intracranial Hypertension

Susan P Mollan, James L Mitchell, Andreas Yiangou, Ryan S Ottridge, Zerin Alimajstorovic, David M Cartwright, Simon J Hickman, Keira A Markey, Rishi Singhal, Abd A Tahrani, Emma Frew, Kristian Brock, Alexandra Jean Sinclair, Susan P Mollan, James L Mitchell, Andreas Yiangou, Ryan S Ottridge, Zerin Alimajstorovic, David M Cartwright, Simon J Hickman, Keira A Markey, Rishi Singhal, Abd A Tahrani, Emma Frew, Kristian Brock, Alexandra Jean Sinclair

Abstract

Background and objectives: The idiopathic intracranial hypertension randomized controlled weight trial (IIH:WT) established that weight loss through bariatric surgery significantly reduced intracranial pressure when compared with a community weight management intervention. This substudy aimed to evaluate the amount of weight loss required to reduce intracranial pressure and to explore the effect of different bariatric surgical approaches.

Methods: IIH:WT was a multicenter randomized controlled trial. Adult women with active idiopathic intracranial hypertension and a body mass index ≥35 kg/m2 were randomized to bariatric surgery or a community weight management intervention (1:1). This per-protocol analysis evaluated the relationship between intracranial pressure, weight loss, and the weight loss methods. A linear hierarchical regression model was used to fit the trial outcomes, adjusted for time, treatment arm, and weight.

Results: Sixty-six women were included, of whom 23 had received bariatric surgery by 12 months; the mean age was 31 (SD 8.7) years in the bariatric surgery group and 33.2 (SD 7.4) years in the dietary group. Baseline weight and intracranial pressure were similar in both groups with a mean weight of 119.5 (SD 24.1) and 117.9 (SD 19.5) kg and mean lumbar puncture opening pressure of 34.4 (SD 6.3) and 34.9 (SD 5.3) cmCSF in the bariatric surgery and dietary groups, respectively. Weight loss was significantly associated with reduction in intracranial pressure (R2 = 0.4734, p ≤ 0.0001). Twenty-four percentage of weight loss (weight loss of 13.3 kg [SD 1.76]) was associated with disease remission (intracranial pressure [ICP] ≤ 25 cmCSF). Roux-en-Y gastric bypass achieved greater, more rapid, and sustained ICP reduction compared with other methods.

Discussion: The greater the weight loss, the greater the reduction in ICP was documented. Twenty four percentage of weight loss was associated with disease remission. Such magnitude of weight loss was unlikely to be achieved without bariatric surgery, and hence, consideration of referral to a bariatric surgery program early for those with active idiopathic intracranial hypertension may be appropriate.

Trial registration: ClinicalTrials.gov Identifier: NCT02124486; ISRCTN registry number ISRCTN40152829; doi.org/10.1186/ISRCTN40152829.

Classification of evidence: This study provides Class II evidence that weight loss after bariatric surgery results in reduction in intracranial pressure in adult women with idiopathic intracranial hypertension. This study is Class II because of the use of a per-protocol analysis.

Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology.

Figures

Figure 1. Reduced Body Weight Significantly Correlates…
Figure 1. Reduced Body Weight Significantly Correlates With Reduced ICP
(A, B) Linear regression analysis plotting change in body weight against change in ICP at 12 and 24 months postbaseline. (C, D) ICP levels of patients categorized according to percentage and absolute weight loss at 12 months since baseline measurements. The dashed red line indicates the idiopathic intracranial hypertension diagnostic threshold of an ICP >25 cmCSF. Data presented as mean ± SEM. Statistical significance was determined by ordinary 1-way analysis of variance with the Tukey multiple comparisons test. CWI = community weight management intervention; ICP = intracranial pressure.
Figure 2. Surgical Intervention is Significantly More…
Figure 2. Surgical Intervention is Significantly More Efficacious at Lowering Body Weight and ICP Than Diet Weight Loss Intervention
Percentage change in diet and surgery groups at baseline, 12-month, and 24-month timepoints for (A) body weight; (B) intracranial pressure; (C) papilledema as measured by OCT volume central thickness; (D) monthly headache days; (E) headache severity; and (F) HIT-6 score; data presented as mean ± SEM. Statistical significance was determined by hierarchical regression modeling in accordance with per-protocol analysis. ***p < 0.001. CWI = community weight management intervention; HIT-6 = headache impact test-6; ICP = intracranial pressure; OCT = optical coherence tomography.
Figure 3. Model-Generated Expected ICP Outcomes for…
Figure 3. Model-Generated Expected ICP Outcomes for Three Notional Participants With Baseline Weights of 150 kg (Top Line), 120 kg (Middle) and 90 kg (Bottom), Allocated to Each Treatment Arm Under 4 Different Weight Loss Scenarios
The expected ICP values are predicted by a hierarchical model fit to the trial outcomes, adjusted for time, intervention, and contemporaneous weight. CWI = community weight management intervention; ICP = intracranial pressure; p.a. = per annum.

References

    1. Mollan SP, Davies B, Silver NC, et al. . Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088-1100.
    1. Virdee J, Larcombe S, Vijay V, Sinclair AJ, Dayan M, Mollan SP. Reviewing the recent developments in idiopathic intracranial hypertension. Ophthalmol Ther. 2020;9(4):767-781.
    1. Mollan SP, Hoffmann J, Sinclair AJ. Advances in the understanding of headache in idiopathic intracranial hypertension. Curr Opin Neurol. 2019;32(1):92-98.
    1. Ghaffari-Rafi A, Mehdizadeh R, Ko AWK, Ghaffari-Rafi S, Leon-Rojas J. Idiopathic intracranial hypertension in the United States: demographic and socioeconomic disparities. Front Neurol. 2020;11:869.
    1. Adderley NJ, Subramanian A, Nirantharakumar K, et al. . Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. 2019;76(9):1088-1098.
    1. Mollan SP, Mytton J, Tsermoulas GT, Sinclair AJ. Idiopathic intracranial hypertension: evaluation of admissions and emergency readmissions through the hospital episode statistic dataset between 2002-2020. Life. 2021;11(5):417.
    1. McCluskey G, Doherty-Allan R, McCarron P, et al. . Meta-analysis and systematic review of population-based epidemiological studies in idiopathic intracranial hypertension. Eur J Neurol. 2018;25(10):1218-1227.
    1. Ko MW, Chang SC, Ridha MA, et al. . Weight gain and recurrence in idiopathic intracranial hypertension: a case-control study. Neurology. 2011;76(18):1564-1567.
    1. Daniels AB, Liu GT, Volpe NJ, et al. . Profiles of obesity, weight gain, and quality of life in idiopathic intracranial hypertension (pseudotumor cerebri). Am J Ophthalmol. 2007;143(4):635-641.
    1. Hornby C, Botfield H, O'Reilly MW, et al. . Evaluating the fat distribution in idiopathic intracranial hypertension using dual-energy X-ray absorptiometry scanning. Neuroophthalmology. 2018;42(2):99-104.
    1. Mollan SP, Tahrani AA, Sinclair AJ. The potentially modifiable risk factor in idiopathic intracranial hypertension: body weight. Neurol Clin Pract. 2021;11(4):e504-e507.
    1. Hornby C, Mollan SP, Mitchell J, et al. . What do transgender patients teach us about idiopathic intracranial hypertension? Neuroophthalmology. 2017;41(6):326-329.
    1. Hornby C, Mollan SP, Botfield H, OʼReilly MW, Sinclair AJ. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol. 2018;38(4):522-530.
    1. O'Reilly MW, Westgate CS, Hornby C, et al. . A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4(6):e125348.
    1. Westgate CS, Botfield HF, Alimajstorovic Z, et al. . Systemic and adipocyte transcriptional and metabolic dysregulation in idiopathic intracranial hypertension. JCI Insight. 2021;6(10):145346.
    1. Kesler A, Hadayer A, Goldhammer Y, Almog Y, Korczyn AD. Idiopathic intracranial hypertension: risk of recurrences. Neurology. 2004;63(9):1737-1739.
    1. Sinclair AJ, Burdon MA, Nightingale PG, et al. . Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701.
    1. Fildes A, Charlton J, Rudisill C, Littlejohns P, Prevost AT, Gulliford MC. Probability of an obese person attaining normal body weight: cohort study using electronic health records. Am J Public Health. 2015;105(9):e54-e59.
    1. Hoffmann J, Mollan SP, Paemeleire K, Lampl C, Jensen RH, Sinclair AJ. European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018;19(1):93.
    1. Mollan S, Hemmings K, Herd CP, Denton A, Williamson S, Sinclair AJ. What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and healthcare professionals. BMJ Open. 2019;9(3):e026573.
    1. Ottridge R, Mollan SP, Botfield H, et al. . Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the idiopathic intracranial hypertension weight trial (IIH:WT) protocol. BMJ Open. 2017;7(9):e017426.
    1. Mollan SP, Mitchell JL, Ottridge RS, et al. . Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial. JAMA Neurol. 2021;78(6):678-686.
    1. Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81(13):1159-1165.
    1. Wilson R, Aminian A, Tahrani AA. Metabolic surgery: a clinical update. Diabetes Obes Metab. 2021;23(suppl 1):63-83.
    1. Rubino F, Gagner M, Gentileschi P, et al. . The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg. 2004;240(2):236-242.
    1. Botfield HF, Uldall MS, Westgate CSJ, et al. . A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus. Sci Transl Med. 2017;9(404):eaan0972.
    1. Mitchell J, Walker J, Lyons H, et al. . 2 IIH Pressure–a randomised, controlled, double blind physiology study of the effect of exenatide on intracranial pressure
    1. BMJ Mil Health 2021;167(3):e1.
    1. Aguiar M, Frew E, Mollan SP, et al. . The health economic evaluation of bariatric surgery versus a community weight management intervention analysis from the idiopathic intracranial hypertension weight trial (IIH:WT). Life (Basel). 2021;11(5):409.
    1. Elliot L, Frew E, Mollan SP, et al. . Cost-effectiveness of bariatric surgery versus community weight management to treat obesity-related idiopathic intracranial hypertension: evidence from a single-payer healthcare system. Surg Obes Relat Dis. 2021;17(7):1310-1316.
    1. Chang SH, Stoll CRT, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014;149(3):275-287.

Source: PubMed

3
Tilaa